The speakers at this year’s Validating Biomarkers for Effective Drug Development will include:
| Dr. Hugh Salter |
Associate Director, Pharmacogenomic |
AstraZeneca |
| Dr. Michael-Friedrich Boettcher |
Global Clinical Pharmacological Project Leader |
Bayer Healthcare |
| Prof. Kewal K. Jain |
CEO |
Jain PharmaBiotech |
| Prof. Christoph W. Turck |
Proteomics and Biomarkers Research Group Leader |
Max Planck Institute of Psychiatry |
| Dr. Thomas Herget |
Senior Director, PLS R&D/New Technology Evaluation Performance and Life Science Chemicals |
Merck Serono |
| Jens Mikkelsen, PhD |
Director, Translational Neurobiology |
Neurosearch |
| Dr. Michael Shi |
Director, Biomarker Project Leader of Exploratory Oncology Development |
Novartis |
| David Reynolds Ph.D |
Senior Director, Experimental Biological Sciences |
Pfizer |
| Dr. Peter Heiss |
Director, Proteomics |
Roche Diagnostics |
| Prof. Harald Hampel |
Chair of Psychiatry, School of Medicine |
Trinity College, Dublin, Ireland |
| |
& Head of the Alzheimer Memorial Center |
University Of Munich, Germany |
| Prof. William Gallagher |
Associate Professor of Cancer Biology, UCD Conway Institute |
University College Dublin |
| Jeroen Aerssens |
Director, Pharmacogenomics |
Tibotec BVBA |
| Dr. Thomas Werner, PhD |
CEO and CSO |
Genomatix Software |
| Stéphane Lucchini, PhD |
Business Manager |
Biovays |
| Marc Tänzer |
M.A., Research Fellow |
TECHNICAL UNIVERSITY OF MUNICH |
